Øivind Foss
Technik-/Wissenschafts-/F&E-Leiter bei ULTIMOVACS ASA
Vermögen: - $ am 30.04.2024
Aktive Positionen von Øivind Foss
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ULTIMOVACS ASA | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Øivind Foss
Ehemalige bekannte Positionen von Øivind Foss
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Pharmalink Oncology AS | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2014 | - |
Smerud Medical Research International AS
Smerud Medical Research International AS BiotechnologyHealth Technology Smerud Medical Research International AS operates as drug development company and contract research organization. The firm specializes in proof-of-concept clinical trials and pivotal regulatory trials. It offers clinical operations, biostatistics, data management, regulatory affairs, medical writing, and consultation. The company was founded by Knut Terje Smerud in 1993 and is headquartered in Oslo, Norway. | Corporate Officer/Principal | - | - |
Ausbildung von Øivind Foss
Norwegian University of Science & Technology | Doctorate Degree |
Statistik
International
Norwegen | 5 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ULTIMOVACS ASA | Health Technology |
Private Unternehmen | 2 |
---|---|
Smerud Medical Research International AS
Smerud Medical Research International AS BiotechnologyHealth Technology Smerud Medical Research International AS operates as drug development company and contract research organization. The firm specializes in proof-of-concept clinical trials and pivotal regulatory trials. It offers clinical operations, biostatistics, data management, regulatory affairs, medical writing, and consultation. The company was founded by Knut Terje Smerud in 1993 and is headquartered in Oslo, Norway. | Health Technology |
Pharmalink Oncology AS |
- Börse
- Insiders
- Øivind Foss
- Erfahrung